@staaroc

staaroc has been a member of Linktree for 3 years and joined in February 2023. The social media accounts linked to from staaroc are: • Facebook • Instagram • TikTok • YouTube • LinkedIn Besides social media accounts, staaroc has populated their site with: • Volunteer | Staaroc • 2026 Voices of LGSOC Patient Survey • Founder Spotlight: Bailey Wolfe • Founder Spotlight: Bailey Wolfe on Why STAAR Began — and Why It Still Matters • Blog | Staaroc • Donate to STAAR • LGSOC Awareness Day—Sept. 9 • Volunteer with STAAR • Share Your Story • LGSOC Video Library • Shop the STAAR store • Woman, 25, with ovarian cancer recalls symptoms that doctors dismissed: 'You’re fine' • FDA approves first LGSOC treatment • Sips & Celebrations sign up • 4th Annual World Ovarian Cancer Coalition Impact Awards • Avutometinib and Defactinib May Benefit Some with LGSOC • STAAR’s fight for better outcomes • The Development and progression of low-grade serous ovarian carcinoma • Woman shares experience battling LGSOC • Tribute to Meredith Blake: Dec. 15, 1971 - July 15, 2024 • Research Update on Recurrent Low-Grade Serous Ovarian Cancer - New York | SHARE Cancer Support • Car show at Wilkes University benefits STAAR • Doctors Dismissed My Pelvic Pain for Years • Endocrine study published in British Journal of Cancer • STAAR blog: Kate Middleton's Cancer Battle • Detection test for ovarian cancer being developed • Results of Global Patient Survey • Orphan Drug Designation Is Beacon of Hope • Verastem Oncology Receives Orphan Drug Designation • STAAR expands study into trametinib resistance at MD Anderson • STAAR funds combination drug trial • STAAR honored for Inspirational Collaborations • Low-Grade Serous Ovarian Cancer 2023 Update • LGSOC Patient Impact Survey Results • Patient-Centered Approaches to LGSOC • Everyday Health • NBC Chicago Health & Wellness report • Journal article: State of LGSOC Science • Let’s Talk About LGSOC • Share it Saturday: B.E.A.C.H. • OC 360 LIVE: Dr. David Gershenson • What’s the Latest in Low-Grade Serous Ovarian Cancer? • Updated Results from Verastem clinical trial